Dow Q3 2026 Earnings: A 14% Pricing Quarter With a Volume Problem

On October 22, 2026, Dow reported third-quarter net sales of $11.3 billion, up 13% year over year, with GAAP net income of $525 million and operating earnings of $0.71 per share — against a $0.19 per-share operating loss a year ago. Read one line deeper and the quarter has a split personality: local price rose 14% while volume fell 1%, and in Asia Pacific volume collapsed 12% on Middle East conflict disruptions. This is a chemicals company being paid more for every pound it sells, and selling fewer pounds.

The Headline Numbers​

Dow's fiscal year is the calendar year; Q3 2026 ended September 30, 2026. Every figure below comes from the earnings release (Exhibit 99.1 to the Form 8-K), which carries full Consolidated Statements of Income, Balance Sheets and Cash Flows — no Q3 10-Q has been filed yet. Annual comparisons come from the FY2025 and FY2024 Forms 10-K.

Net income here is attributable to Dow Inc. common stockholders, the line EPS is computed from; consolidated net income was $525 million, with $67 million attributable to noncontrolling interests. The deltas reveal a quarter won almost entirely above the gross-profit line: cost of sales rose only 7% on 13% higher revenue, so gross profit nearly doubled and carried everything beneath it. Below operating income the picture is noisier — sundry income fell from $185 million to $50 million a year ago's quarter held a $110 million divestiture gain — but the $647 million of extra gross profit swamps every offset. Cash is the cleanest beat: $1,839 million of operating cash flow funded $706 million of capex and still left $1,133 million of free cash flow, roughly double last year's.

Revenue Deep Dive​

All three operating segments grew sales, but the mix underneath is pure price:

Packaging & Specialty Plastics is the quarter. Its $5.8 billion of sales grew 18% on a 17% local-price gain — "higher polyethylene and functional polymers prices in all regions," in the release's words — and operating EBIT nearly tripled to $585 million on "higher integrated margins as a result of higher polyethylene prices." Management's demand language here is careful rather than triumphant: "Polyethylene demand remained resilient, with year-over-year volume growth excluding supply constraints associated with the Middle East conflict." Resilient is not robust, and the qualifier does real work — volume grew only where supply allowed it. The constructive detail sits inside the Hydrocarbons & Energy business, where Olefins and Aromatics posted higher price and volume in EMEAI, "enabled by the restart of our previously idled cracker in the region." A cracker restart is a supply-side vote of confidence you can check next quarter.

Industrial Intermediates & Infrastructure grew 8% on 16% pricing against a 7% volume decline — the most extreme price-over-volume quarter of the three. Both businesses raised prices in all regions, but Polyurethanes volumes sagged on Middle East conflict impacts while Industrial Solutions found genuine demand: "increased demand for AI infrastructure and energy applications, as well as higher ethylene oxide project-related catalyst sales." That AI-infrastructure line is the closest Dow comes to a growth narrative this quarter, and it lives in a catalyst business, not a GPU. Operating EBIT swung from a $47 million loss to a $176 million profit, helped by an accounting tailwind the release discloses plainly: "the suspension of the recognition of equity losses from Sadara."

Performance Materials & Coatings is the balanced one: 5% price, 3% volume, operating EBIT nearly doubling to $154 million. The release credits "the closure of the Barry, U.K. siloxanes plant" alongside price and volume gains — downstream silicones volumes grew in all regions on "growth in consumer, electronics and home care applications," more than offsetting the upstream volumes lost to the shutdown. This is the self-help story in miniature: close high-cost upstream capacity, keep the downstream pounds.

Geographically, the conflict map is legible: the U.S. & Canada (+16%), EMEAI (+18%) and Latin America (+15%) all grew double digits, while Asia Pacific sales fell 3% on a 12% volume decline, "where impacts from the Middle East conflict are most pronounced."

The Margin Story​

Gross margin expanded nearly five points year over year, and the mechanism is visible in two lines: revenue up 13%, cost of sales up only 7%. The release says higher prices and self-help benefits "more than offset higher raw materials and logistics costs" — note that input costs rose; Dow did not ride falling feedstocks. This is pricing power, not cost relief. Operating leverage did the rest: R&D and SG&A combined grew roughly in line with sales while amortization and restructuring charges shrank, so the $647 million of incremental gross profit flowed into a $707 million operating EBIT improvement.

Set against history, the quarter reads as recovery rather than peak. A 12.2% gross margin merely restores the FY2024 level of 10.7% after FY2025's trough of 6.3%, and the 7.9% operating EBIT margin has headroom against any mid-cycle chemicals benchmark. The bearish cross-check is sequential, not annual: operating EBITDA of $1,553 million trails Q2's $2,312 million, and net income of $525 million trails Q2's $802 million. Both comparisons come from the release's own trailing-twelve-months table. The year-over-year story is a V-shaped recovery; the sequential story says Q2 was the V's peak so far.

The One Big Question: What Does Dow Earn When the Conflict Premium Fades?​

Strip the quarter to its variance table and the question asks itself:

Every dollar of growth is price. Some of that price is structural — downstream mix, contract resets — but the release ties the polyethylene spike and the Asia Pacific volume hole to the same Middle East conflict. Conflict pricing is, by nature, rented: it persists exactly as long as the disruption does, and it reverses the moment idled capacity like that EMEAI cracker restarts everywhere at once. Dow's own outlook language conspicuously avoids claiming an upcycle — there is no "demand exceeds supply" anywhere in the release, only "resilient" demand and "supply constraints associated with the Middle East conflict." Management is not calling a cycle turn; it is harvesting a dislocation while cutting costs.

The GAAP-to-operating bridge shows how much of the headline survives that framing:

Significant items were a net $(84) million pretax charge — $69 million of Transform to Outperform costs and $31 million of 2025 Restructuring implementation costs, partly offset by a $69 million litigation gain on the Nova Chemicals matter, less a $53 million loss on early debt extinguishment — so the operating number is genuinely cleaner than GAAP, not flattered by it. The self-help ledger is the durable half of the bull case: CEO Karen Carter said the company is "on track to achieve the upsized $700 million in growth and productivity benefits in 2026, as well as the approximately $2 billion in total uplift by the end of next year," with "sequential gains from the first of our three European asset shutdowns" already landing. Price may be rented, but a shuttered plant saves money in every quarter. The bear case is that $539 million of restructuring and asset charges in the first nine months says the transformation is still consuming cash faster than it visibly returns it.

Tracking a $61 Billion Company in Plain Text​

A chemicals conglomerate is exactly the kind of company double-entry bookkeeping clarifies: every pound of polyethylene sold has to reconcile to cash collected, inventory drawn, or a receivable — and the balance sheet shows which. This ledger follows how we model every company, with Dow's Dow Inc.-parent statements (not the TDCC subsidiary statements printed in the same 10-Ks) modeled across FY2024, FY2025 and FY2026Q3. Beancount sign conventions apply in the snippet below: Income is negative (credit), Expenses positive (debit).

; FY2026Q3 Income Statement — three months ended September 30, 2026
; Check: −11,267 + 9,889 + 180 + 408 + 40 + 9 + (−12) + (−50) + (−50) + 211 + 117 + 67 + 458 = 0 ✓
 
2026-09-30 * "Dow Inc." "FY2026Q3 Income Statement"
  Income:Revenue                              -11267 MUSD  ; net sales
  Expenses:CostOfRevenue                         9889 MUSD  ; cost of sales
  Expenses:ResearchAndDevelopment                    180 MUSD  ; research and development expenses
  Expenses:SellingGeneralAdministrative               408 MUSD  ; selling, general and administrative expenses
  Expenses:AmortizationOfAcquiredIntangibles            40 MUSD  ; amortization of intangibles
  Expenses:ImpairmentsAndRestructuring                   9 MUSD  ; restructuring and asset related charges - net
  Income:OtherNet                                        -12 MUSD  ; equity in earnings of nonconsolidated affiliates
  Income:OtherNet                                        -50 MUSD  ; sundry income - net (Nova Chemicals litigation gain 69 less loss on early extinguishment of debt 53)
  Income:OtherNet                                        -50 MUSD  ; interest income
  Expenses:Interest                                       211 MUSD  ; interest expense and amortization of debt discount
  Expenses:IncomeTax                                      117 MUSD  ; provision for income taxes
  Expenses:OtherNet                                        67 MUSD  ; net income attributable to noncontrolling interests, deducted as the filing does
  Equity:Adjustments                                      458 MUSD  ; net income available for Dow Inc. common stockholders offset (RE set by balance assertion)

The one balance-sheet number that tells the deleveraging story is total debt: notes payable plus current and long-term debt stood at $18,161 million at year-end 2025 and $17,539 million at September 30 — a $622 million paydown that corroborates management's "approximately $600 million year-to-date" to the dollar. Cash rose $326 million over the same span, to $4,142 million. The working-capital release is visible too: trade receivables fell $540 million sequentially (from $6,430 million at June 30) and inventories $209 million, which is where the "more than $400 million of working capital" released in the quarter came from. Watch the offsetting line, though — other noncurrent obligations rose from $7,201 million to $8,772 million in nine months, a $1.6 billion long-tail build that deserves a question on the call.

The Multi-Year Arc​

Three periods, one arc — collapse, trough, rebound:

FY2025 was the trough in every dimension that matters: revenue down 7%, operating EBIT down 84% to $422 million, a $2,623 million attributable net loss after $1,856 million of restructuring and impairment charges, and negative $1,417 million of free cash flow. Debt rose to fund the gap. Nine months into 2026 the mirror image is forming: operating EBIT of $2,689 million already exceeds the whole of FY2024, operating cash flow of $4,287 million exceeds any full year in this ledger's window, and free cash flow of $2,446 million has flipped from deeply negative. The ledger starts at FY2024 — the two most recent audited annuals plus the current quarter — which is exactly the window that frames this as a trough-to-recovery story rather than a single good print. The compounding question is whether 2027 looks like FY2024 with better costs, which is what the promised $2 billion of transformation uplift would deliver.

The Verdict: Bull vs. Bear​

Bull Case

• Pricing power is broad, not a one-asset spike. Local price rose in all three segments and polyethylene prices rose in all regions; P&SP's 17% price gain on flat-ish volume is a franchise repricing, not a mix artifact.
• Self-help is quantified, dated and landing. $700 million of benefits in 2026 and ~$2 billion by end of 2027, with the first European shutdown already contributing sequential gains — falsifiable within two quarters.
• Cash conversion is back. $1,839 million of quarterly operating cash flow, $1,133 million of free cash flow, and 83.7% trailing-twelve-month cash flow conversion prove the earnings are collected, not accrued.
• The balance sheet is healing while the P&L recovers. $622 million of debt retired year-to-date, cash up $326 million, and the dividend ($253 million in the quarter) covered more than four times by free cash flow.
• Industrial Intermediates has inflected. A $223 million year-over-year operating EBIT swing to $176 million, with AI-infrastructure and energy demand opening a genuine growth pocket in Industrial Solutions.

Bear Case

• Volume fell 1% while price rose 14% — and Asia Pacific volume fell 12%. Every demand signal management declines to claim ("resilient," never "robust" or "exceeding supply") confirms the growth is entirely priced, and conflict pricing reverses.
• The quarter weakened sequentially. Net income of $525 million trails Q2's $802 million and operating EBITDA of $1,553 million trails Q2's $2,312 million; the V-shape's right side is sloping down, not up.
• Receivables are outrunning sales. Trade receivables are up 23.7% year over year ($4,762 million to $5,890 million) against 13% sales growth — a full quarter of the pricing gain is still uncollected.
• Restructuring is a permanent line item. $539 million of restructuring and asset charges in nine months, $84 million of significant items this quarter alone, and a transformation program that keeps upsizing its targets is a program still spending.
• The long tail keeps growing. Other noncurrent obligations rose $1.6 billion in nine months to $8,772 million, and pension plus asbestos liabilities still total ~$4.9 billion — leverage the debt line doesn't show.

Our Take: Buy the self-help, rent the price. Dow's cost transformation is specific enough to audit — three European shutdowns, a closed siloxanes plant, $700 million this year — and the cash flow proves the P&L is real. But a quarter built on +14% price and −1% volume, with earnings already fading from Q2's peak, is a quarter to value on mid-cycle margins, not annualized. If polyethylene pricing holds through Q1 and the second European shutdown lands on schedule, the $2 billion 2027 target turns this into a structurally higher-margin Dow; if Asia Pacific volumes stay down double digits, this was the top of a conflict trade. The ledger will show which within two quarters.